tiprankstipranks
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF

Compare Innate Pharma SA (IPHYF) vs. Competitors

27 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma SA
$2.16
$176.08M
-2.94
13.79%
Abivax SA
€104.70
€9.04B
-23.13
1055.68%
2 Buy
0 Hold
0 Sell
Moderate Buy
Nanobiotix
€28.70
€1.72B
-65.23
744.86%
3 Buy
0 Hold
0 Sell
Strong Buy
Transgene
€0.94
€231.51M
-3.47
-18.02%
OSE Immunotherapeutics SA
€3.33
€99.20M
-2.49
-39.19%
1 Buy
0 Hold
0 Sell
Moderate Buy
Cellectis SA
€3.86
€222.47M
-5.27
116.91%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHYF
Innate Pharma SA
1.65
0.20
13.79%
FR:ABVX
Abivax SA
63.10
56.54
861.89%
FR:NANO
Nanobiotix
31.26
27.54
739.19%
FR:TNG
Transgene
0.81
-0.09
-10.56%
FR:OSE
OSE Immunotherapeutics SA
3.82
-2.34
-38.00%
FR:ALCLS
Cellectis SA
2.95
1.61
120.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts